Isla joined Stratagem in 2015 after spending 7 years working as in-house patent counsel at GSK (GlaxoSmithKline). At GSK she was responsible for the patent portfolios and patent strategy for a number of biopharmaceutical platforms and assets including domain antibodies and monoclonal antibodies. Isla qualified as a European Patent Attorney and Chartered Patent Attorney in 2000 and has previously worked in private practice. She is experienced in drafting, filing and prosecuting patent applications for a range of life science technologies. She also has experience of advising on collaborations and licensing deals, freedom to operate, as well as representing clients in opposition and appeal proceedings at the European Patent Office.
Isla has a degree in Natural Sciences from the University of Cambridge and a PhD in cell biology from the Institute of Cancer Research in London. Prior to joining the patent profession, Isla worked as a technology transfer officer for the Ludwig Institute of Cancer Research.